Episode 16: Impact of Cannabis on Brain Health
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Henry Mahncke, PhD, on the impact of cannabis on cognitive health.
Episode 16 of the Patient Care Online Primary Viewpoints podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.
The Primary Viewpoints podcast features informative conversations with health care experts, opinion leaders, and practicing physicians, about what impacts primary care medicine today.
In episode 16, Henry Mahncke, PhD, joins us to talk about the connection between cannabis and brain health, including potential benefits and challenges and key points primary care clinicians can use to effectively educate patients.
Dr Mahncke is a research neuroscientist, who serves as CEO of Posit Science Corporation, the leading provider of plasticity-based brain training and assessments. Dr. Mahncke is also principal investigator on several government grants and has been involved in numerous research studies on the impact of cognitive training on older adults.
Click here to subscribe to the Primary Viewpoints podcast. Be sure to leave a rating and review for the show. Thanks for listening!
The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It Works
December 16th 2024The coverage with evidence development (CED) policy requires enrollment in an active clinical trial for an adult to be eligible for Medicare coverage of treatment for Alzheimer's disease.
